A detailed history of Canopy Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Canopy Partners, LLC holds 10,003 shares of MRK stock, worth $994,798. This represents 0.49% of its overall portfolio holdings.

Number of Shares
10,003
Previous 10,536 5.06%
Holding current value
$994,798
Previous $1.3 Billion 12.91%
% of portfolio
0.49%
Previous 0.61%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $59,242 - $68,741
-533 Reduced 5.06%
10,003 $1.14 Billion
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $61,776 - $66,347
499 Added 4.97%
10,536 $1.3 Billion
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $102,482 - $119,414
905 Added 9.91%
10,037 $1.32 Billion
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $914,843 - $995,570
9,132 New
9,132 $1 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Canopy Partners, LLC Portfolio

Follow Canopy Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canopy Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canopy Partners, LLC with notifications on news.